Pharmaceutical Injections

Zepbound was approved by the Food and Drug Administration in November 2023 for weight loss in adults with obesity or who are overweight with at least one related condition like type 2 diabetes, high cholesterol, or high blood pressure).

When used for weight loss, Mounjaro also helps reduce your appetite. This can decrease the calories you consume, which may lead to weight loss. Also, keep in mind that Mounjaro is prescribed along with exercise and a balanced diet, and these factors can also help you lose weight.
Zepbound was approved by the Food and Drug Administration in November 2023 for weight loss in adults with obesity or who are overweight with at least one related condition like type 2 diabetes, high cholesterol, or high blood pressure).

Saxenda (liraglutide [rDNA origin] injection) is a glucagon-like peptide-1 (GLP-1) receptor agonist. GLP-1 is a physiological regulator of appetite and calorie intake, and the GLP-1 receptor is present in several areas of the brain involved in appetite regulation.

Saxenda® (liraglutide) injection 3 mg is an injectable prescription medicine used for adults with excess weight (BMI ≥27) who also have weight-related medical problems or obesity (BMI ≥30), and children aged 12-17 years with a body weight above 132 pounds (60 kg) and obesity to help them lose weight and keep the weight


Saxenda comes as a liquid solution inside a prefilled injection pen. Saxenda is used to help with weight loss in: adults and some children who have obesity

Saxenda® (liraglutide) injection 3 mg is an injectable prescription medicine used for adults with excess weight (BMI ≥27) who also have weight-related medical problems or obesity (BMI ≥30), and children aged 12-17 years with a body weight above 132 pounds (60 kg) and obesity to help them lose weight and keep the weight


Saxenda comes as a liquid solution inside a prefilled injection pen. Saxenda is used to help with weight loss in: adults and some children who have obesity

Saxenda® (liraglutide) injection 3 mg is an injectable prescription medicine used for adults with excess weight (BMI ≥27) who also have weight-related medical problems or obesity (BMI ≥30), and children aged 12-17 years with a body weight above 132 pounds (60 kg) and obesity to help them lose weight and keep the weight


Saxenda comes as a liquid solution inside a prefilled injection pen. Saxenda is used to help with weight loss in: adults and some children who have obesity

Liraglutide, sold under the brand names Victoza and Saxenda among others, is an anti-diabetic medication used to treat type 2 diabetes, and chronic obesity. It is a second-line therapy for diabetes following first-line therapy with metformin.

Saxenda. Liraglutide. Saxenda is a Subcutaneous Injection, Solution in the Human Prescription Drug category.

Saxenda^® (liraglutide) injection 3 mg is an injectable prescription medicine used for adults with excess weight (BMI ≥27) who also have weight-related medical problems or obesity (BMI ≥30), and children aged 12-17 years with a body weight above 132 pounds (60 kg) and obesity to help them lose weight and keep the weight

After 4 weeks of treatment, Saxenda users saw an average weight loss of b 3-4% of their starting body weight. After 2 months of treatment, people lost an average of 5% of their body weight, when Saxenda was combined with a healthy diet and exercise.

Saxenda (liraglutide) is used for weight loss and to help keep weight off once weight has been lost, it is used for obese adults or overweight adults who also have weight-related medical problems. Saxenda can be used in children aged 12 to 17 years who with obesity and who have a bodyweight above 132 pounds (60 kg).

Tirzepatide, a GIP/GLP-1R unimolecular dual agonist, regulates metabolism via both peripheral organs and the central nervous system.


Medication: Tirzepatide



Tirzepatide, sold under the brand name Mounjaro among others, is an antidiabetic medication used for the treatment of type 2 diabetes and for weight loss. Tirzepatide is administered via subcutaneous injections.


AHFS/Drugs.com: Monograph
ATC code: A10BX16 (WHO) QA10BX16 (WHO)
Bioavailability: 80%
Elimination half-life: 5 days
Excretion: Urine and faeces
License data: US DailyMed: Tirzepatide
Metabolism: Proteolytic cleavage, β-oxidation of fatty diacid section and amide hydrolysis.


Tirzepatide Neuropeptide Analogue of Gastric Inhibitory Polypeptide

Tirzepatide, sold under the brand name Mounjaro among others, is an antidiabetic medication used for the treatment of type 2 diabetes and for weight loss. Tirzepatide is administered via subcutaneous injections (under the skin).
 

Saxenda® is an injectable medicine used for adults with excess weight who may also have weight-related medical problems or obesity and children aged 12-17 years old.


Novo Nordisk. Saxenda is approved by the US FDA for the treatment of chronic weight management. Credit: Novo Nordisk. Saxenda contains an active ingredient called liraglutide, which is a glucagon-like peptide-1 (GLP-1) analogue.

Tirzepatide Medication

Tirzepatide is an antidiabetic medication used for the treatment of type 2 diabetes and for weight loss. Tirzepatide is administered via subcutaneous injections. It is sold under the brand names Mounjaro for diabetes treatment, and Zepbound for weight loss. 

AHFS/Drugs.com: Monograph

ATC code: A10BX16 (WHO) QA10BX16 (WHO)

Bioavailability: 80%

Elimination half-life: 5 days

Excretion: Urine and faeces

License data: US Daily

Med: Tirzepatide

Metabolism: Proteolytic cleavage, β-oxidation of fatty diacid section and amide hydrolysis

Tirzepatide works by activating two proteins called glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) which belong to a group of hormones called incretins

Buy Novo Nordisk Wegovy Semaglutide Injection Online Wegovy Semaglutide Injections Weight Loss

Wegovy acts on areas of the brain which are involved in regulating your appetite. It increases feelings of fullness, reduces feelings of hunger and reduces the preference for high-fat foods. It also reduces blood sugar by promoting the release of insulin when blood sugar levels are high.

Wegovy^® is an injectable prescription medication for adults with obesity (BMI ≥30) or overweight (excess weight) (BMI ≥27) who also have weight-related medical problems, to help them lose weight and keep it off. Wegovy^® should be used with a reduced-calorie meal plan and increased physical activity.

Wegovy (semaglutide) is used in addition to a lower-calorie diet and exercise plan to help with weight loss in certain adults and children 12 years of age and older. It's also proven to lower the risk for heart attack, stroke, and death due to heart problems in adults with a larger body size and heart disease.